Skip to content

Clinical trials

Completed Amyloidosis trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Amyloidosis Status: Completed Country / region: France Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20071
20084
20092
20101
20133
20142
20151
20164
20171
20194
20203
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer6
Ionis Pharmaceuticals, Inc.4
Alnylam Pharmaceuticals3
Assistance Publique - Hôpitaux de Paris1
Bellus Health Inc. - a GSK company1
C.T. Development America, Inc.1
Centre Hospitalier Departemental Vendee1
European Society for Blood and Marrow Transplantation1
French Cardiology Society1
Institut National de la Santé Et de la Recherche Médicale, France1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Amyloidosis28
Amyloid Neuropathies, Familial10
Alzheimer Disease6
Polyneuropathies5
Cardiomyopathies4
Immunoglobulin Light-chain Amyloidosis3
Amyloid Neuropathies1
Amyloidosis, Familial1
Anosmia1
Aortic Valve Stenosis1

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.